Compounds > n-n-propyl-n-n-butyl-beta-dopamine
Page last updated: 2024-09-04

n-n-propyl-n-n-butyl-beta-dopamine and n,n-di-n-propyldopamine

n-n-propyl-n-n-butyl-beta-dopamine has been researched along with n,n-di-n-propyldopamine in 1 studies

Compound Research Comparison

Studies
(n-n-propyl-n-n-butyl-beta-dopamine)		Trials
(n-n-propyl-n-n-butyl-beta-dopamine)		Recent Studies (post-2010)
(n-n-propyl-n-n-butyl-beta-dopamine)		Studies
(n,n-di-n-propyldopamine)		Trials
(n,n-di-n-propyldopamine)		Recent Studies (post-2010) (n,n-di-n-propyldopamine)
171045012

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brenner, M; DeMarinis, RM; Franz, RG; Hieble, JP; Ross, ST; Sarau, HM; Wilson, JW1

Other Studies

1 other study(ies) available for n-n-propyl-n-n-butyl-beta-dopamine and n,n-di-n-propyldopamine

ArticleYear
Dopamine receptor agonists: 3-allyl-6-chloro-2,3,4,5-tetrahydro- 1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol and a series of related 3-benzazepines.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:5

    Topics: Alkylation; Animals; Benzazepines; Caudate Nucleus; Cyclic AMP; Fenoldopam; Norepinephrine; Rabbits; Receptors, Dopamine

1986